Lymphoproliferative disorders with concurrent HHV8 and EBV infection: beyond primary effusion lymphoma and germinotropic lymphoproliferative disorder

Lymphoproliferative disorders with concurrent HHV8 and EBV infection: beyond primary effusion... IntroductionHuman herpesvirus 8 (HHV8), also known as Kaposi sarcoma‐associated herpesvirus (KSHV), was discovered in 1994 from Kaposi sarcoma tissues obtained from patients with acquired immunonodeficiency syndrome. In addition to Kaposi sarcoma, HHV8 is also associated with four types of lymphoproliferative disorder (LPD): primary effusion lymphoma (PEL), a subset of multicentric Castleman disease (MCD), HHV8+ diffuse large B cell lymphoma and germinotropic LPD. Among these four entities, PEL and germinotropic LPD also have concurrent EBV infection. PEL is a large B‐cell lymphoma with immunoblastic/plasmablastic morphological features that presents usually as a serous effusion without a detectable tumour mass. This neoplasm often occurs in the setting of immunocompromised conditions, such as human immunodeficiency virus (HIV) infection and following organ transplantation. Rarely, PEL can present as a solid tumour mass designated as a solid or extracavitary variant of PEL. Germinotropic LPD is a very rare disease, first described in three patients with localised lymphadenopathy. Patients have no history of immunodeficiency and usually present with solitary lymphadenopathy, especially in the head and neck area. Histologically, there is an immunoblastic/plasmablastic proliferation preferentially involving germinal centres. The atypical cells are monotypic by immunophenotype, but polyclonal at the molecular level. In contrast to PEL, patients with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Histopathology Wiley

Lymphoproliferative disorders with concurrent HHV8 and EBV infection: beyond primary effusion lymphoma and germinotropic lymphoproliferative disorder

Loading next page...
 
/lp/wiley/lymphoproliferative-disorders-with-concurrent-hhv8-and-ebv-infection-8r5vzcloaT
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 John Wiley & Sons Ltd
ISSN
0309-0167
eISSN
1365-2559
D.O.I.
10.1111/his.13428
Publisher site
See Article on Publisher Site

Abstract

IntroductionHuman herpesvirus 8 (HHV8), also known as Kaposi sarcoma‐associated herpesvirus (KSHV), was discovered in 1994 from Kaposi sarcoma tissues obtained from patients with acquired immunonodeficiency syndrome. In addition to Kaposi sarcoma, HHV8 is also associated with four types of lymphoproliferative disorder (LPD): primary effusion lymphoma (PEL), a subset of multicentric Castleman disease (MCD), HHV8+ diffuse large B cell lymphoma and germinotropic LPD. Among these four entities, PEL and germinotropic LPD also have concurrent EBV infection. PEL is a large B‐cell lymphoma with immunoblastic/plasmablastic morphological features that presents usually as a serous effusion without a detectable tumour mass. This neoplasm often occurs in the setting of immunocompromised conditions, such as human immunodeficiency virus (HIV) infection and following organ transplantation. Rarely, PEL can present as a solid tumour mass designated as a solid or extracavitary variant of PEL. Germinotropic LPD is a very rare disease, first described in three patients with localised lymphadenopathy. Patients have no history of immunodeficiency and usually present with solitary lymphadenopathy, especially in the head and neck area. Histologically, there is an immunoblastic/plasmablastic proliferation preferentially involving germinal centres. The atypical cells are monotypic by immunophenotype, but polyclonal at the molecular level. In contrast to PEL, patients with

Journal

HistopathologyWiley

Published: Jan 1, 2018

Keywords: ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial